GLABF
Price
$0.63
Change
-$0.11 (-14.86%)
Updated
Jun 4 closing price
Capitalization
46.51M
IDRSF
Price
$1.86
Change
+$0.18 (+10.71%)
Updated
May 23 closing price
Capitalization
501.9M
Interact to see
Advertisement

GLABF vs IDRSF

Header iconGLABF vs IDRSF Comparison
Open Charts GLABF vs IDRSFBanner chart's image
GEMINA LABORATORIES
Price$0.63
Change-$0.11 (-14.86%)
Volume$100
Capitalization46.51M
Idorsia AG
Price$1.86
Change+$0.18 (+10.71%)
Volume$108
Capitalization501.9M
GLABF vs IDRSF Comparison Chart
Loading...
View a ticker or compare two or three
VS
GLABF vs. IDRSF commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLABF is a Hold and IDRSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (GLABF: $0.63 vs. IDRSF: $1.86)
Brand notoriety: GLABF and IDRSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLABF: 1% vs. IDRSF: 7%
Market capitalization -- GLABF: $46.51M vs. IDRSF: $501.9M
GLABF [@Biotechnology] is valued at $46.51M. IDRSF’s [@Biotechnology] market capitalization is $501.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLABF’s FA Score shows that 1 FA rating(s) are green whileIDRSF’s FA Score has 0 green FA rating(s).

  • GLABF’s FA Score: 1 green, 4 red.
  • IDRSF’s FA Score: 0 green, 5 red.
According to our system of comparison, GLABF is a better buy in the long-term than IDRSF.

Price Growth

GLABF (@Biotechnology) experienced а -15.28% price change this week, while IDRSF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.92%. For the same industry, the average monthly price growth was +17.56%, and the average quarterly price growth was +3.51%.

Industries' Descriptions

@Biotechnology (+11.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
IDRSF($502M) has a higher market cap than GLABF($46.5M). IDRSF YTD gains are higher at: 118.824 vs. GLABF (14.775). GLABF has higher annual earnings (EBITDA): -3.46M vs. IDRSF (-258.35M). IDRSF has more cash in the bank: 103M vs. GLABF (41.6K). GLABF has less debt than IDRSF: GLABF (1.46M) vs IDRSF (1.26B). IDRSF has higher revenues than GLABF: IDRSF (74.1M) vs GLABF (0).
GLABFIDRSFGLABF / IDRSF
Capitalization46.5M502M9%
EBITDA-3.46M-258.35M1%
Gain YTD14.775118.82412%
P/E RatioN/A4.54-
Revenue074.1M-
Total Cash41.6K103M0%
Total Debt1.46M1.26B0%
FUNDAMENTALS RATINGS
IDRSF: Fundamental Ratings
IDRSF
OUTLOOK RATING
1..100
45
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FAZ4.930.04
+0.82%
Direxion Daily Financial Bear 3X ETF
SEIQ36.56-0.06
-0.16%
SEI Enhanced US Large Cap Qual Fac ETF
VMBS45.55-0.17
-0.37%
Vanguard Mortgage-Backed Secs ETF
FQAL67.71-0.31
-0.46%
Fidelity Quality Factor ETF
HYDR19.58-0.52
-2.59%
Global X Hydrogen ETF

GLABF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLABF has been loosely correlated with ELVAF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GLABF jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLABF
1D Price
Change %
GLABF100%
N/A
ELVAF - GLABF
36%
Loosely correlated
N/A
TNFA - GLABF
29%
Poorly correlated
-2.62%
IDRSF - GLABF
23%
Poorly correlated
N/A
VYGR - GLABF
22%
Poorly correlated
-0.75%
ENTO - GLABF
8%
Poorly correlated
+9.90%
More

IDRSF and

Correlation & Price change

A.I.dvisor tells us that IDRSF and KRRO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IDRSF and KRRO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDRSF
1D Price
Change %
IDRSF100%
N/A
KRRO - IDRSF
29%
Poorly correlated
+3.96%
VYGR - IDRSF
24%
Poorly correlated
-0.75%
ENLV - IDRSF
23%
Poorly correlated
-1.08%
GLABF - IDRSF
23%
Poorly correlated
N/A
IVEVF - IDRSF
21%
Poorly correlated
N/A
More